Predictivity of clinical efficacy of sublingual immunotherapy (SLIT) based on sensitisation pattern to molecular allergens in children with allergic rhinoconjunctivitis.
Sign Up to like & getrecommendations! Published in 2017 at "Allergologia et immunopathologia"
DOI: 10.1016/j.aller.2017.01.001
Abstract: BACKGROUND The diagnostic and therapeutic approach to grass pollen allergy is now possible by detecting specific IgE (sIgE) to its allergenic components. AIM To evaluate the correlation between the sensitisation to different molecular Phleum pratense… read more here.
Keywords: immunotherapy; clinical efficacy; sensitisation; group ... See more keywords
An international Delphi study on the burden of allergic rhinoconjunctivitis and urticaria and the role of bilastine among current treatment options.
Sign Up to like & getrecommendations! Published in 2023 at "Expert review of clinical immunology"
DOI: 10.1080/1744666x.2023.2214729
Abstract: BACKGROUND allergic rhinoconjunctivitis and chronic urticaria are common histamine-driven diseases, exerting detrimental effects on cognitive functions, sleep, daily activities and quality of life. Non-sedating second-generation H1-antihistamines are the first line treatment of choice. Aim of… read more here.
Keywords: allergic rhinoconjunctivitis; second generation; role; treatment ... See more keywords
Health and economic impact of subcutaneous allergen immunotherapy in patients with pollen-induced allergic rhinoconjunctivitis: real-word evidence from the Czech Republic.
Sign Up to like & getrecommendations! Published in 2022 at "Immunotherapy"
DOI: 10.2217/imt-2022-0143
Abstract: Background: The prevalence of allergic rhinoconjunctivitis (AR) has been increasing over the years, and allergen immunotherapy (AIT) remains the only disease-modifying treatment. However, cost-effectiveness data remain scarce. Methods: In this single-arm, noninterventional, prospective, multicenter study,… read more here.
Keywords: allergic rhinoconjunctivitis; ait; pollen induced; induced allergic ... See more keywords
Open-label safety assessment of bilastine in elderly patients with allergic rhinoconjunctivitis and/or urticaria.
Sign Up to like & getrecommendations! Published in 2018 at "Allergy and asthma proceedings"
DOI: 10.2500/aap.2018.39.4136
Abstract: BACKGROUND Bilastine is an H1-antihistamine approved for symptomatic treatment of patients with allergic rhinoconjunctivitis or urticaria. The safety profile of bilastine in clinical trials of allergic rhinoconjunctivitis or urticaria, assessed by type and frequency of… read more here.
Keywords: safety profile; safety; bilastine; rhinoconjunctivitis urticaria ... See more keywords
Prevention of omalizumab for seasonal allergic rhinoconjunctivitis: a retrospective cohort study
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Immunology"
DOI: 10.3389/fimmu.2022.913424
Abstract: Background Allergic rhinoconjunctivitis (ARC) is an allergic disease that is characterized by conjunctival and nasal symptoms such as edema and congestion of conjunctiva, rhinorrhea, sneezing, and blocked nose. Seasonal ARC (SARC) is usually induced by… read more here.
Keywords: allergic rhinoconjunctivitis; preventative efficacy; efficacy omalizumab; treatment ... See more keywords